Press Releases
Fique a par dos últimos desenvolvimentos nas áreas da Alergologia e Imunologia Clínica no Congresso da EAACI de 2024 em Valência, Espanha
EAACI Congress 2024 http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALÊNCIA, Espanha, March 19, 2024 (GLOBE NEWSWIRE) — A Academia Europeia de Alergia e Imunologia Clínica (EAACI), com mais de 16 mil associados de 125 países, organiza anualmente o seu congresso para revelar a mais recente
O último roteiro da plataforma de inteligência de decisão da Quantexa foca-se em ajudar as empresas e as agências governamentais a preparar os dados para a IA
A Quantexa apoia uma onda crescente de organizações que utilizam dados, análises e IA a quebrar os silos A parceria com a Microsoft disponibiliza imediatamente a Plataforma de Inteligência de Decisão da Quantexa no Microsoft Azure Marketplace; a empresa compromete-se
La dernière feuille de route de la plateforme d’intelligence décisionnelle de Quantexa met l’accent sur l’aide apportée aux entreprises et aux agences gouvernementales pour que leurs données soient prêtes pour l’IA
Quantexa accompagne le nombre croissant d’entreprises qui utilisent les données, l’analyse et l’IA pour briser les silos Grâce au partenariat avec Microsoft, la plateforme d’intelligence décisionnelle de Quantexa est désormais disponible sur Microsoft Azure Marketplace ; l’entreprise s’engage à développer
Women in the Digital Economy Fund: USAID, the Bill & Melinda Gates Foundation, and Partners Launch WiDEF
NEW YORK, N.Y., March 12, 2024 (GLOBE NEWSWIRE) — The Women in the Digital Economy Fund (WiDEF), a five-year $60.5 million investment to accelerate progress on closing the global gender digital divide, announces its first call for applications with recorded
Fortrea Assina Contrato Definitivo de Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato Ela cria as melhores soluções independentes de Randomização e Gestão de Fornecimento de
Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de recherche contractuelle Création de solutions autonomes de premier ordre pour la randomisation, la gestion
Latest Quantexa Decision Intelligence Platform Roadmap Puts Focus on Helping Enterprises and Government Agencies to Get Data Ready For AI
Quantexa supporting rising wave of organizations using data, analytics, and AI to break down silos Partnership with Microsoft makes Quantexa’s Decision Intelligence Platform immediately available on Microsoft Azure Marketplace; company commits to build solutions natively on Azure Technology preview
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure-play contract research organization Creates standalone best-in-class Randomization and Trial Supply Management and Patient Access solutions positioned for differentiation and growth DURHAM, N.C.,